Showing 2971-2980 of 3844 results for "".
- Novartis: New Data Show Cosentyx Has Durable Response Across Psoriatic Diseasehttps://practicaldermatology.com/news/novartis-new-data-show-cosentyx-has-durable-response-across-psoriatic-disease/2460068/A new comprehensive analysis shows the long-term efficacy and safety of secukinumab in multiple manifestations of psoriatic disease, including moderate-to-severe plaque-type, nail and palmoplantar psoriasis, psoriatic arthritis and ankylosing spondylitis. Data are derived from key Phase 3, random
- Now Available: neuLASH Professional and neuBROW Professionalhttps://practicaldermatology.com/news/now-available-neulash-professional-and-neubrow-professional/2459956/New from Skin Research Professional and Olive and Delmar, neuLASH PROFESSIONAL™ and neuBROW PROFESSIONAL™ are available in all new, next-generation, professional-strength formulations. neuLASH PROFESSIONAL™ is a peptide serum promoting longer-looking lashes and neuBROW PROFESS
- Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2019 Aspire Higher Scholarship Programhttps://practicaldermatology.com/news/calling-all-students-ortho-dermatologics-now-accepting-applications-for-the-2019-aspire-higher-scholarship-program/2459978/Ortho Dermatologics is accepting applications for its 2019 Aspire Higher scholarship program, which will award $90,000 total in scholarships to nine students who have been treated for a dermatologic condition. Students can apply for the Aspire Higher scholarship through April 26, 2
- Jeuveau from Evolus Now FDA Cleared for Aesthetic Injectionhttps://practicaldermatology.com/news/jeuveau-from-evolus-now-fda-cleared-for-aesthetic-injection/2459914/The FDA has approved Jeuveau™ (prabotulinumtoxinA-xvfs), the lead product from Evolus, Inc., for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults. It will be available to physicians this sp
- New Data Show Cosentyx Improves Quality of Life in Patients Being Treated for Psoriasishttps://practicaldermatology.com/news/new-data-show-cosentyx-improves-quality-of-life-in-patients-being-treated-for-psoriasis/2459924/Novartis shared results from a pooled analysis of four Phase 3 clinical trials demonstrating patients with moderate to severe plaque psoriasis (PsO) treated with Cosentyx (secukinumab) 300mg reported improvements in mobility, self-care, and usual activities components of the EQ-5D-3L questionnair
- Hologic's Cynosure Division Launches TempSure Surgical RF Technology in North Americahttps://practicaldermatology.com/news/hologics-cynosure-division-launches-tempsure-surgical-rf-technology-in-north-america/2457541/Hologic, Inc.’s Cynosure division is launching the U.S. Food and Drug Administration (FDA)-cleared
- Study: Lipid that Aids Normal Skin Turnover May Help Psoriasishttps://practicaldermatology.com/news/study-lipid-that-aids-normal-skin-turnover-may-help-psoriasis/2457495/A lipid that helps keep skin cell turnover on track may help restore healthy turnover in psoriasis, investigators say. Topical application of the lipid phosphatidylglycerol, or PG, on a mouse model of psoriasis reduced inflammation as well as characteristic, raised skin lesions, they report in th
- Nanoparticulate-based Sunscreens May Not Be So Dangerous After Allhttps://practicaldermatology.com/news/nanoparticulate-based-sunscreens-may-not-be-so-dangerous-after-all/2457499/Zinc oxide nanoparticles used in sunscreen neither penetrate the skin nor cause cellular toxicity after repeated applications, according to a study out of University of Queensland (UQ) and University of South Australia, The
- Sinclair Pharma: Acquisition by Huadong Medicine Company Limited Now Completehttps://practicaldermatology.com/news/sinclair-pharma-acquisition-by-huadong-medicine-company-limited-now-complete/2457500/Huadong Medicine Company Limited (HMC) has acquired Sinclair Pharma Limited, a global aesthetics company headquartered in London, UK, in a deal worth approximately $222 million. HMC is a well-known Chinese pharmaceutical listed company that has established a leading aesthetics business in China a
- Ortho Dermatologics' Altreno Now Available in the UShttps://practicaldermatology.com/news/ortho-dermatologics-altreno-now-available-in-the-us/2457526/Ortho Dermatologics launched Altreno (tretinoin) Lotion, 0.05% for the topical treatment of acne vulgaris in patients 9 years of age and older. Altreno Lotion is the first and only tretinoin available in a lotion for acne. Altreno Lotion has been shown to be effective and generally well-tolerated